Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Lexaria Bioscience Corp
LEXXCurrent price
2.26 USD
-0.08 USD (-3.42%)
Last closed
2.3 USD
Company
www.lexariabioscience.com
ISIN
US52886N4060
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
41 188 136 USD
Yield for 12 month
+73.85 %
1Y
3Y
5Y
10Y
15Y
LEXX
Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. The company's DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins, pain medications, hormones, PDE5 inhibitors, antivirals, oral nicotine and its analogs, and cannabinoids. Its DehydraTECH technology evaluates therapeutic indications, including hypertension, heart disease, and diabetes; and is suitable for a variety of product formats, such as pharmaceuticals, nutraceuticals, over the counter, and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada. Address: 740 McCurdy Road, Kelowna, BC, Canada, V1X 2P7
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10 USDP/E ratio
–Dividend Yield
–Current Year
+226 208 USD
Last Year
+255 397 USD
Current Quarter
+84 000 USD
Last Quarter
+145 000 USD
Current Year
+194 708 USD
Last Year
+183 556 USD
Current Quarter
+68 926 USD
Last Quarter
+129 069 USD
Key Figures LEXX
1 year
3 years
5 years
10 years
EBITDA
-4 533 468 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-38.21 %
PEG Ratio
–
Return On Equity TTM
-70.66 %
Wall Street Target Price
10 USD
Revenue TTM
411 019 USD
Book Value
0.64 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
8.1 %
Dividend Yield
–
Gross Profit TTM
183 556 USD
Earnings per share
-0.44 USD
Diluted Eps TTM
-0.44 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics LEXX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History LEXX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:30
Payout Ratio
–
Last Split Date
12.01.2021
Dividend Date
12.01.2021
Stock Valuation LEXX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
79.8633
Price Sales TTM
100.2098
Enterprise Value EBITDA
-7.2229
Price Book MRQ
4.0689
Financials LEXX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LEXX
For 52 weeks
1.2 USD
6.85 USD
50 Day MA
2.98 USD
Shares Short Prior Month
311 095
200 Day MA
3.01 USD
Short Ratio
2.94
Shares Short
275 682
Short Percent
1.81 %
BeatStart